| Trade Names: | |
| Synonyms: | |
| Status: | Approved |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | N01AX13 |
| UNII: | K50XQU1029 |
Structure
| InChI Key | GQPLMRYTRLFLPF-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | N2O |
| Molecular Weight | 44.01 |
| AlogP | 0.34 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 0.0 |
| Polar Surface Area | 51.21 |
| Molecular species | ACID |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 3.0 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
| Pain | 3 | D010146 | ClinicalTrials |
| Burns | 3 | D002056 | ClinicalTrials |
| Pregnancy | 3 | D011247 | ClinicalTrials |
| Complex Regional Pain Syndromes | 3 | D020918 | ClinicalTrials |
| Tonsillitis | 2 | D014069 | ClinicalTrials |
| Depressive Disorder, Treatment-Resistant | 2 | D061218 | ClinicalTrials |
| Alcohol-Related Disorders | 2 | D019973 | ClinicalTrials |
| Bipolar Disorder | 2 | D001714 | ClinicalTrials |
| Opioid-Related Disorders | 2 | D009293 | ClinicalTrials |
| Stress Disorders, Post-Traumatic | 2 | D013313 | ClinicalTrials |
| Obsessive-Compulsive Disorder | 2 | D009771 | ClinicalTrials |
| Anemia, Sickle Cell | 2 | D000755 | ClinicalTrials |
| Depressive Disorder, Major | 2 | D003865 | ClinicalTrials |
| Anxiety | 0 | D001007 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 10024-97-2 |
| ChEBI | 17045 |
| ChEMBL | CHEMBL1234579 |
| DrugBank | DB06690 |
| DrugCentral | 4238 |
| EPA CompTox | DTXSID8021066 |
| FDA SRS | K50XQU1029 |
| Human Metabolome Database | HMDB0035807 |
| KEGG | C00887 |
| PDB | N2O |
| PubChem | 948 |
| SureChEMBL | SCHEMBL23060 |
CONTENTS